The crowd is surging, thank you for meeting you
Release time:
2021-03-22
Last weekend, my best friend Lili and I went to the cinema to watch "The Surge". The movie is about the cold-blooded killer Zhou Quan played by Andy Lau and the down-and-out group played by Xiao Yang playing Chen Xiaomeng. By chance, they exchanged stories of life. At the beginning of the
movie, what I saw was a dark and cruel assassination scene, which really made my heart beat faster, but as the plot continued to deepen, and then the painting style changed, I discovered that this movie It's not just a crime comedy.
Chen Xiaomeng was ready to hang himself in his rented room because he lost hope for life. I saw him hanging on a stool and struggling to death. Fortunately, the rope suddenly broke and he survived. However, Zhou Quan lost his memory in a slip accident. Chen Xiaomeng took the opportunity to exchange identities with him. At this point my curiosity was aroused: a killer, a group act, what kind of spark would their exchange of identities create?
Seeing Chen Xiaomeng touching the killer's well-rounded car steering wheel and a lot of cash, the cinema burst into laughter, and my nervousness finally eased a lot. Then Chen Xiaomeng began his extreme life of enjoyment. On the other hand, he had a bad life with amnesia. He lived in Chen Xiaomeng's rental room and saw a rope hanging over his head. He thinks he has an unbearable past, but he has not lost his belief in survival. Relying on his own hands, he has made the originally smelly and messy living environment clean and orderly, while Chen Xiaomeng on the other side has made the luxurious hotel room where he lives all over the floor. This scene makes me feel that human nature is really difficult to change.
But can a group act be a good killer? Can a killer be a group act? The movie gives the answer. After amnesia, the comprehensive became kind and naive, but without the training of professional schools, it was not good for group performance and made others laugh. He has always maintained a positive and optimistic attitude towards life, and has not been knocked down by life. He keeps cheering himself on every day and takes notes in a small notebook. So he started from the group performance, through his own continuous efforts and learning, he was successfully recognized by the director, and became a little famous in the crew, and his originally unsightly life became so warm and beautiful. However, Chen Xiaomeng did not have the cold-blooded ruthlessness and professional skills of a killer. In the end, Hui Jie, the villain's employer, asked him to assassinate a fake pregnant woman. He actually liked the target so much that he gave up the assassination and gave the other party a large sum of money to persuade her to flee the city.
Chen Xiaomeng's life was very embarrassing at the beginning. He thought of many kinds of actions to end his life, but he was lucky to survive. Through the exchange of identities, he got the rich life he yearned for, but he still degenerates, squandering money and being lazy. A group performance from the bottom of the society, after changing the identity is still not enterprising, always want to get something for nothing. However, since the memory loss, Zhou Quan has been more kind and naive than before. He does not abandon himself in life, redefines his new life, and encounters love and obtains a new life.
In real life, some people, when they encounter a little difficulty or bumpy, take a pessimistic attitude and complain about all kinds of life. In the same situation, the killer and the group acted in a completely different posture. After amnesia, the comprehensive life of the sleepy life is so positive, neither humble nor arrogant, from the bottom of the society step by step to live out their own style, live out another kind of colorful life, which is really inspiring! The course of counter attack after the comprehensive exchange of identities tells us very well that there is no smooth road in life, and even there may not be a glimmer of hope, but please don't give up on yourself, for the dream in your heart, hesitate to move forward, as long as you work hard, you will become lucky, and you will certainly be able to clear the clouds and see the sun!
At the end of the movie, the comprehensive amnesia woke up in the rain on the set. He remembered his own memory, but he chose love, gave up his identity as a killer, and resolutely went to negotiate with his employer alone to find a way to rescue the son of the mistress. He wanted to be with the mistress as Chen Xiaomeng forever. In order to save Zhou Quan, Chen Xiaomeng bravely stood up for the first time and became a leading role, trying to deceive his employer into releasing Zhou Quan and the son of the mistress through his acting skills. In the end, the deception was discovered, and Zhou Quan and Chen Xiaomeng fought back to back together against a dozen people. After all, they were outnumbered and defeated. It turns out that Chen Xiaomeng, who was originally cowardly and timid, can also become bold and responsible for friendship.
Of course, only in movies can there be an exchange of identities between top killers and down-and-out performers. In reality, there will be no such drama, but everyone can have family, love and friendship. Although many things may not be satisfactory at first, as long as we always have hope for life, we can fill that vacancy through our own continuous efforts and hard work, let our life counter attack!
The crowds are surging, thank you for meeting you. (Huang Yuan)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31